PMID: 91 MeierJ
Wegovy is approved by Health Canada for chronic weight management in adults with a specific BMI or weight-related health conditions
2022 DOI: 10.1016/j.cmet.2022.07.013 PMID: 35985340 Read on PubMed The Lancet LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial Urva S, Coskun T, Loh MT, et al
Side effects typical of GLP-1 RAs include:22 Nausea Bloating Vomiting Diarrhea Abdominal pain Belching Flatulence Most of these symptoms are associated with these drugs' ability to slow down your digestion.12 As you acclimate to your bodys changing digestive rhythm and consume fewer calories per meal, these side effects tend to dissipate
Q What happens if something goes wrong? Your care team